Structural Design and Immunogenicity of a Novel Self‐Adjuvanting Mucosal Vaccine Candidate for SARS ‐ CoV ‐2 Expressed in Plants
Plant Biotechnology Journal · 2026
DOI: 10.1111/pbi.70278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plant Biotechnology Journal, 2026. Verfasst von Mi-Young Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and the Institute for Molecular Biology and Genetics, Jeonbuk National University, Jeonju, Republic of Korea. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19 Vaccines, COVID-19. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EC H2020 Maria Sklodowska ITN, National Research Foundation (NRF) of Korea, MRC-KHIDI UK-Korea partnership award.
Abstract (Originalsprache)
Mucosal vaccination for COVID‐19 to boost preexisting though insufficient systemic and local/mucosal immunity remains an attractive prospect but there are currently no licensed mucosal vaccines against this infection. Here, using a plant expression system, we developed a novel mucosal vaccine platform for respiratory viruses and demonstrated its application in the context of SARS‐CoV‐2 infection. In addition to the antigen itself, the PCF (Platform CTB‐Fc) vaccine candidate incorporates two molecular adjuvants, the IgG‐Fc antibody fragment and the nontoxic cholera toxin B subunit (CTB), with the first targeting the vaccine to IgG receptors on antigen‐presenting cells, and the second providing local adjuvanticity by targeting cellular gangliosides in the mucosae. We demonstrated that this vaccine candidate is highly immunogenic in mice, inducing virus‐neutralising systemic and mucosal antibodies as well as tissue resident memory T cells in the lungs. We also demonstrated that SRBD‐PCF is recognised by immune cells from exposed or vaccinated individuals, and that circulating antibodies also bind to the antigen within the vaccine, forming immune complexes (IC). Finally, with a view of respiratory delivery, we demonstrated that the vaccine can be aerosolised without loss of material or biological activity, and that it is noncytotoxic and nonhaemolytic to human cells. Furthermore, we demonstrate that the plant expression system represents a suitable platform to produce these complex, multifunctional macromolecules capable of simultaneously binding to multiple targets. Our data strongly support the case for a safe, self‐adjuvanting mucosal COVID‐19 vaccine development, as means to boosting both systemic and mucosal immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and the Institute for Molecular Biology and Genetics, Jeonbuk National University, Jeonju, Republic of Korea.
- Institute for Infection and Immunity, City St George's University of London, London, UK.
- Université Claude Bernard Lyon 1, Villeurbanne, France.
- ImmunXperts SA, A Q2 Solutions Company, Charleroi, Belgium.
- Gencellbiotech Inc., Wanju, Republic of Korea.
ORCID-Profile: Julian K C Ma, Rajko Reljic
Förderung
- EC H2020 Maria Sklodowska ITN
- National Research Foundation (NRF) of Korea
- MRC-KHIDI UK-Korea partnership award
- St George's Concept Development Award
Zitieren
APA
Kim, M. Y., Tran, A. C., Kim, J., Ayuk, H. S., Sparrow, A., Bossi, L., Brown, M., Vergara, E. J., Göritzer, K., Groppelli, E., Kwon, T. H., Ma, J. K. C., Jang, Y. S., & Reljic, R. (2026). Structural Design and Immunogenicity of a Novel Self‐Adjuvanting Mucosal Vaccine Candidate for SARS ‐ CoV ‐2 Expressed in Plants. Plant Biotechnology Journal. https://doi.org/10.1111/pbi.70278
Vancouver
Kim MY, Tran AC, Kim J, Ayuk HS, Sparrow A, Bossi L, et al. Structural Design and Immunogenicity of a Novel Self‐Adjuvanting Mucosal Vaccine Candidate for SARS ‐ CoV ‐2 Expressed in Plants. Plant Biotechnology Journal. 2026. doi:10.1111/pbi.70278
BibTeX
@article{Kim2026,
author = {Kim, Mi-Young and Tran, Andy Cano and Kim, Ju and Ayuk, Humblenoble Stembridge and Sparrow, Adam and Bossi, Lorenzo and Brown, Megan and Vergara, Emil Joseph and Göritzer, Kathrin and Groppelli, Elisabetta and Kwon, Tae-Ho and Ma, Julian K C and Jang, Yong-Suk and Reljic, Rajko},
title = {Structural Design and Immunogenicity of a Novel Self‐Adjuvanting Mucosal Vaccine Candidate for SARS ‐ CoV ‐2 Expressed in Plants},
journal = {Plant Biotechnology Journal},
year = {2026},
doi = {10.1111/pbi.70278}
}
EUVIMED